Current concepts in glucocorticoid resistance

Steroids

Volumn 77, Issue 11, 2012, Pages 1041-1049

  Yang, Nan ^a   Ray, David W ^a   Matthews, Laura C ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Glucocorticoid; Glucocorticoid receptor; Glucocorticoid resistance; Inflammation

Indexed keywords

CYTOKINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLYCOPROTEIN P; TRANSCRIPTION FACTOR;

ASTHMA; CHRONIC DISEASE; CORTICOSTEROID THERAPY; CROHN DISEASE; DNA POLYMORPHISM; DRUG SENSITIVITY; GENOTYPE; HEREDITY; HUMAN; HYPOXIA; INFLAMMATION; LEUKEMIA; LOW DRUG DOSE; NEOPLASM; OXIDATIVE STRESS; PHENOTYPE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT FAILURE; TREATMENT RESPONSE; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

ANOXIA; ANTI-INFLAMMATORY AGENTS; CELLULAR MICROENVIRONMENT; CHRONIC DISEASE; CYTOKINES; DRUG RESISTANCE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; MUTATION; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 84865490712     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2012.05.007     Document Type: Review

References (138)

1. A. McMaster, and D.W. Ray Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects Exp Physiol 92 2 2007 299 309
2. P.J. Barnes, and I.M. Adcock Glucocorticoid resistance in inflammatory diseases Lancet 373 9678 2009 1905 1917
3. I.S. De, R. Franca, S. Martelossi, A. Ventura, and G. Decorti Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease World J Gastroenterol 17 9 2011 1095 1108
4. N. Niu, V. Manickam, K.R. Kalari, I. Moon, L.L. Pelleymounter, and B.W. Eckloff Human glucocorticoid receptor alpha gene (NR3C1) pharmacogenomics: gene resequencing and functional genomics J Clin Endocrinol Metab 94 8 2009 3072 3084
5. K.L. Gross, N.Z. Lu, and J.A. Cidlowski Molecular mechanisms regulating glucocorticoid sensitivity and resistance Mol Cell Endocrinol 300 1-2 2009 7 16
6. J.W. Thornton Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions Proc Natl Acad Sci U S A 98 10 2001 5671 5676
7. R.A. Frieler, H. Meng, S.Z. Duan, S. Berger, G. Schutz, and Y. He Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia Stroke 42 1 2011 179 185
8. N.Z. Lu, and J.A. Cidlowski Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes Mol Cell 18 3 2005 331 342
9. K.L. Gross, R.H. Oakley, A.B. Scoltock, C.M. Jewell, and J.A. Cidlowski Glucocorticoid receptor alpha isoform-selective regulation of antiapoptotic genes in osteosarcoma cells: a new mechanism for glucocorticoid resistance Mol Endocrinol 25 7 2011 1087 1099
10. N. Ismaili, and M.J. Garabedian Modulation of glucocorticoid receptor function via phosphorylation Ann N Y Acad Sci 1024 2004 86 101
11. Z. Orbak Glucocorticoid resistance Biochemistry (Mosc) 71 10 2006 1073 1081
12. R. Kumar, D.E. Volk, J. Li, J.C. Lee, D.G. Gorenstein, and E.B. Thompson TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain Proc Natl Acad Sci U S A 101 47 2004 16425 16430
13. W. Chen, I. Rogatsky, and M.J. Garabedian MED14 and MED1 differentially regulate target-specific gene activation by the glucocorticoid receptor Mol. Endocrinol. 2005
14. B.F. Luisi, W.X. Xu, Z. Otwinowski, L.P. Freedman, K.R. Yamamoto, and P.B. Sigler Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA Nature 352 6335 1991 497 505
15. R.K. Bledsoe, V.G. Montana, T.B. Stanley, C.J. Delves, C.J. Apolito, and D.D. McKee Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition Cell 110 1 2002 93 105
16. N.Z. Lu, S.E. Wardell, K.L. Burnstein, D. DeFranco, P.J. Fuller, and V. Giguere International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors Pharmacol Rev 58 4 2006 782 797
17. V. Giguere, S.M. Hollenberg, M.G. Rosenfeld, and R.M. Evans Functional domains of the human glucocorticoid receptor Cell 46 5 1986 645 652
18. K.B. Horwitz, T.A. Jackson, D.L. Bain, J.K. Richer, G.S. Takimoto, and L. Tung Nuclear receptor coactivators and corepressors Mol Endocrinol 10 10 1996 1167 1177
19. C.K. Glass, D.W. Rose, and M.G. Rosenfeld Nuclear receptor coactivators Curr Opin Cell Biol 9 2 1997 222 232
20. D.M. Heery, E. Kalkhoven, S. Hoare, and M.G. Parker A signature motif in transcriptional co-activators mediates binding to nuclear receptors Nature 387 6634 1997 733 736
21. K.R. Yamamoto, B.D. Darimont, R.L. Wagner, and J.A. Iniguez-Lluhi Building transcriptional regulatory complexes: signals and surfaces Cold Spring Harb Symp Quant Biol 63 1998 587 598
22. N.J. McKenna, R.B. Lanz, and B.W. O'Malley Nuclear receptor coregulators: cellular and molecular biology Endocr Rev 20 3 1999 321 344
23. T. Kucera, M. Waltner-Law, D.K. Scott, R. Prasad, and D.K. Granner A point mutation of the AF2 transactivation domain of the glucocorticoid receptor disrupts its interaction with steroid receptor coactivator 1 J Biol Chem 277 29 2002 26098 26102
24. B.M. Necela, and J.A. Cidlowski Crystallization of the human glucocorticoid receptor ligand binding domain: a step towards selective glucocorticoids Trends Pharmacol Sci 24 2 2003 58 61
25. R. Kumar, and E.B. Thompson Gene regulation by the glucocorticoid receptor:structure:function relationship J Steroid Biochem Mol Biol 94 5 2005 383 394
26. L. Matthews, A. Berry, V. Ohanian, J. Ohanian, H. Garside, and D. Ray Caveolin mediates rapid glucocorticoid effects, and couples glucocorticoid action to the antiproliferative programme Mol Endocrinol 28 22 2008 1320 1330
27. J.M. Harrell, P.J. Murphy, Y. Morishima, H. Chen, J.F. Mansfield, and M.D. Galigniana Evidence for glucocorticoid receptor transport on microtubules by dynein J Biol Chem 279 52 2004 54647 54654
28. L. Matthews, J. Johnson, A. Berry, P. Trebble, A. Cookson, and D. Spiller Cell cycle phase regulates glucocorticoid receptor function PLoS One 6 7 2011 e22289
29. S.C. Biddie, S. John, P.J. Sabo, R.E. Thurman, T.A. Johnson, and R.L. Schiltz Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding Mol Cell 43 1 2011 145 155
30. T.C. Voss, R.L. Schiltz, M.H. Sung, P.M. Yen, J.A. Stamatoyannopoulos, and S.C. Biddie Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism Cell 146 4 2011 544 554
31. J. Hess, P. Angel, and M. Schorpp-Kistner AP-1 subunits: quarrel and harmony among siblings J Cell Sci 117 Pt 25 2004 5965 5973
32. F. Paliogianni, A. Raptis, S.S. Ahuja, S.M. Najjar, and D.T. Boumpas Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT J Clin Invest 91 4 1993 1481 1489
33. L.I. McKay, and J.A. Cidlowski Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways Endocr Rev 20 4 1999 435 459
34. D.F. Callen, E. Baker, R.N. Simmers, R. Seshadri, and I.B. Roninson Localization of the human multiple drug resistance gene, MDR1, to 7q21.1 Hum Genet 77 2 1987 142 144
35. R.J. Farrell, A. Murphy, A. Long, S. Donnelly, A. Cherikuri, and D. O'Toole High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy Gastroenterology 118 2 2000 279 288
36. S. Tsujimura, K. Saito, M. Nawata, S. Nakayamada, and Y. Tanaka Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis Ann Rheum Dis 67 3 2008 380 388
37. U. Potocnik, I. Ferkolj, D. Glavac, and M. Dean Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis Genes Immun 5 7 2004 530 539
38. P.J. Barnes Mechanisms and resistance in glucocorticoid control of inflammation J Steroid Biochem Mol Biol 120 2-3 2010 76 85
39. D.M. Hurley, D. Accili, C.A. Stratakis, M. Karl, N. Vamvakopoulos, and E. Rorer Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance J Clin Invest 87 2 1991 680 686
40. M. Karl, S.W. Lamberts, S.D. Detera-Wadleigh, I.J. Encio, C.A. Stratakis, and D.M. Hurley Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene J Clin Endocrinol Metab 76 3 1993 683 689
41. D.M. Malchoff, A. Brufsky, G. Reardon, P. McDermott, E.C. Javier, and C.H. Bergh A mutation of the glucocorticoid receptor in primary cortisol resistance J Clin Invest 91 5 1993 1918 1925
42. M. Karl, S.W. Lamberts, J.W. Koper, D.A. Katz, N.E. Huizenga, and T. Kino Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation Proc Assoc Am Physicians 108 4 1996 296 307
43. T. Kino, R.H. Stauber, J.H. Resau, G.N. Pavlakis, and G.P. Chrousos Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking J Clin Endocrinol Metab 86 11 2001 5600 5608
44. M. Ruiz, U. Lind, M. Gafvels, G. Eggertsen, J. Carlstedt-Duke, and L. Nilsson Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance Clin Endocrinol (Oxf) 55 3 2001 363 371
45. E. Charmandari, T. Kino, T. Ichijo, K. Zachman, A. Alatsatianos, and G.P. Chrousos Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477H and hGRalphaG679S associated with generalized glucocorticoid resistance J Clin Endocrinol Metab 91 4 2006 1535 1543
46. A. Vottero, T. Kino, H. Combe, P. Lecomte, and G.P. Chrousos A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators J Clin Endocrinol Metab 87 6 2002 2658 2667
47. B.B. Mendonca, M.V. Leite, M. de Castro, T. Kino, L.L. Elias, and T.A. Bachega Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene J Clin Endocrinol Metab 87 4 2002 1805 1809
48. E. Charmandari, A. Raji, T. Kino, T. Ichijo, A. Tiulpakov, and K. Zachman A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity J Clin Endocrinol Metab 90 6 2005 3696 3705
49. E. Charmandari, T. Kino, T. Ichijo, W. Jubiz, L. Mejia, and K. Zachman A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance J Clin Endocrinol Metab 92 10 2007 3986 3990
50. S.K. McMahon, C.J. Pretorius, J.P. Ungerer, N.J. Salmon, L.S. Conwell, and M.A. Pearen Neonatal complete generalized glucocorticoid resistance and growth hormone deficiency caused by a novel homozygous mutation in Helix 12 of the ligand binding domain of the glucocorticoid receptor gene (NR3C1) J Clin Endocrinol Metab 95 1 2010 297 302
51. P. Trebble, L. Matthews, J. Blaikley, A.W. Wayte, G.C. Black, and A. Wilton Familial glucocorticoid resistance caused by a novel frameshift glucocorticoid receptor mutation J Clin Endocrinol Metab 95 12 2010 E490 E499
52. A.C. Vingerhoeds, J.H. Thijssen, and F. Schwarz Spontaneous hypercortisolism without Cushing's syndrome J Clin Endocrinol Metab 43 5 1976 1128 1133
53. G.P. Chrousos, A. Vingerhoeds, D. Brandon, C. Eil, M. Pugeat, and M. DeVroede Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease J Clin Invest 69 6 1982 1261 1269
54. E. Charmandari, T. Kino, T. Ichijo, and G.P. Chrousos Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder J Clin Endocrinol Metab 93 5 2008 1563 1572
55. H. Russcher, P. Smit, E.L. van den Akker, E.F. van Rossum, A.O. Brinkmann, and F.H. de Jong Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression J Clin Endocrinol Metab 90 10 2005 5804 5810
56. H. Russcher, E.F. van Rossum, F.H. de Jong, A.O. Brinkmann, S.W. Lamberts, and J.W. Koper Increased expression of the glucocorticoid receptor-A translational isoform as a result of the ER22/23EK polymorphism Mol Endocrinol 19 7 2005 1687 1696
57. E.F. van Rossum, and S.W. Lamberts Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition Recent Prog Horm Res 59 2004 333 357
58. C.M. Jewell, and J.A. Cidlowski Molecular evidence for a link between the N363S glucocorticoid receptor polymorphism and altered gene expression J Clin Endocrinol Metab 92 8 2007 3268 3277
59. W.J. Tissing, J.P. Meijerink, M.L. den Boer, B. Brinkhof, E.F. van Rossum, and E.R. van Wering Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia Clin Cancer Res 11 16 2005 6050 6056
60. T. Zhang, P. Haws, and Q. Wu Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation Genome Res 14 1 2004 79 89
61. J.D. Turner, and C.P. Muller Structure of the glucocorticoid receptor (NR3C1) gene 5′ untranslated region: identification, and tissue distribution of multiple new human exon 1 J Mol Endocrinol 35 2 2005 283 292
62. E. Presul, S. Schmidt, R. Kofler, and A. Helmberg Identification, tissue expression, and glucocorticoid responsiveness of alternative first exons of the human glucocorticoid receptor J Mol Endocrinol 38 1-2 2007 79 90
63. R.H. Oakley, M. Sar, and J.A. Cidlowski The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function J Biol Chem 271 16 1996 9550 9559
64. N.Z. Lu, and J.A. Cidlowski The origin and functions of multiple human glucocorticoid receptor isoforms Ann N Y Acad Sci 1024 2004 102 123
65. D.W. Ray, J.R. Davis, A. White, and A.J. Clark Glucocorticoid receptor structure and function in glucocorticoid-resistant small cell lung carcinoma cells Cancer Res 56 14 1996 3276 3280
66. I.J. Brogan, I.A. Murray, G. Cerillo, M. Needham, A. White, and J.R. Davis Interaction of glucocorticoid receptor isoforms with transcription factors AP-1 and NF-kappaB: lack of effect of glucocorticoid receptor beta Mol Cell Endocrinol 157 1-2 1999 95 104
67. C.A. Longui, A. Vottero, P.C. Adamson, D.E. Cole, T. Kino, and O. Monte Low glucocorticoid receptor alpha/beta ratio in T-cell lymphoblastic leukemia Horm Metab Res 32 10 2000 401 406
68. P. de Lange, C.M. Segeren, J.W. Koper, E. Wiemer, P. Sonneveld, and A.O. Brinkmann Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells Cancer Res 61 10 2001 3937 3941
69. E.G. Haarman, G.J. Kaspers, R. Pieters, M.M. Rottier, and A.J. Veerman Glucocorticoid receptor alpha, beta and gamma expression vs in vitro glucocorticod resistance in childhood leukemia Leukemia 18 3 2004 530 537
70. Y. Koga, A. Matsuzaki, A. Suminoe, H. Hattori, S. Kanemitsu, and T. Hara Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children Pediatr Blood Cancer 45 2 2005 121 127
71. W.J. Tissing, M. Lauten, J.P. Meijerink, M.L. den Boer, J.W. Koper, and P. Sonneveld Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia Haematologica 90 9 2005 1279 1281
72. L.J. Lewis-Tuffin, C.M. Jewell, R.J. Bienstock, J.B. Collins, and J.A. Cidlowski Human glucocorticoid receptor beta binds RU-486 and is transcriptionally active Mol Cell Biol 27 6 2007 2266 2282
73. R.H. Oakley, C.M. Jewell, M.R. Yudt, D.M. Bofetiado, and J.A. Cidlowski The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action J Biol Chem 274 39 1999 27857 27866
74. C. Rivers, A. Levy, J. Hancock, S. Lightman, and M. Norman Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing J Clin Endocrinol Metab 84 11 1999 4283 4286
75. C. Beger, K. Gerdes, M. Lauten, W.J. Tissing, I. Fernandez-Munoz, and M. Schrappe Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach Br J Haematol 122 2 2003 245 252
76. P.A. Moalli, S. Pillay, N.L. Krett, and S.T. Rosen Alternatively spliced glucocorticoid receptor messenger RNAs in glucocorticoid-resistant human multiple myeloma cells Cancer Res 53 17 1993 3877 3879
77. J.G. Scammell, W.B. Denny, D.L. Valentine, and D.F. Smith Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates Gen Comp Endocrinol 124 2 2001 152 165
78. J.G. Scammell, J.A. Tucker, J.A. King, C.M. Moore, J.L. Wright, and C.M. Tuck-Muller A kidney epithelial cell line from a Bolivian squirrel monkey In Vitro Cell Dev Biol Anim 38 5 2002 258 261
79. G.M. Wochnik, J. Ruegg, G.A. Abel, U. Schmidt, F. Holsboer, and T. Rein FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells J Biol Chem 280 6 2005 4609 4616
80. S. Kojika, K. Sugita, T. Inukai, M. Saito, K. Iijima, and T. Tezuka Mechanisms of glucocorticoid resistance in human leukemic cells: implication of abnormal 90 and 70 kDa heat shock proteins Leukemia 10 6 1996 994 999
81. X. Qian, Y. Zhu, W. Xu, and Y. Lin Glucocorticoid receptor and heat shock protein 90 in peripheral blood mononuclear cells from asthmatics Chin Med J (Engl) 114 10 2001 1051 1054
82. M. Matysiak, B. Makosa, A. Walczak, and K. Selmaj Patients with multiple sclerosis resisted to glucocorticoid therapy: abnormal expression of heat-shock protein 90 in glucocorticoid receptor complex Mult Scler 14 7 2008 919 926
83. W.J. Tissing, J.P. Meijerink, M.L. den Boer, B. Brinkhof, and R. Pieters MRNA expression levels of (co)chaperone molecules of the glucocorticoid receptor are not involved in glucocorticoid resistance in pediatric ALL Leukemia 19 5 2005 727 733
84. I.M. Beck, B.W. Vanden, L. Vermeulen, K.R. Yamamoto, G. Haegeman, and B.K. De Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases Endocr Rev 30 7 2009 830 882
85. N. Dephoure, C. Zhou, J. Villen, S.A. Beausoleil, C.E. Bakalarski, and S.J. Elledge A quantitative atlas of mitotic phosphorylation Proc Natl Acad Sci U S A 105 31 2008 10762 10767
86. M.D. Krstic, I. Rogatsky, K.R. Yamamoto, and M.J. Garabedian Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor Mol Cell Biol 17 7 1997 3947 3954
87. W. Chen, T. Dang, R.D. Blind, Z. Wang, C.N. Cavasotto, and A.B. Hittelman Glucocorticoid receptor phosphorylation differentially affects target gene expression Mol Endocrinol 22 8 2008 1754 1766
88. A.L. Miller, M.S. Webb, A.J. Copik, Y. Wang, B.H. Johnson, and R. Kumar P38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211 Mol Endocrinol 19 6 2005 1569 1583
89. A.J. Galliher-Beckley, J.G. Williams, J.B. Collins, and J.A. Cidlowski Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles Mol Cell Biol 28 24 2008 7309 7322
90. M. Itoh, M. Adachi, H. Yasui, M. Takekawa, H. Tanaka, and K. Imai Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation Mol Endocrinol 16 10 2002 2382 2392
91. K. Ito, S. Yamamura, S. Essilfie-Quaye, B. Cosio, M. Ito, and P.J. Barnes Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression J Exp Med 203 1 2006 7 13
92. N. Nader, G.P. Chrousos, and T. Kino Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications FASEB J 23 5 2009 1572 1583
93. S. Tian, H. Poukka, J.J. Palvimo, and O.A. Janne Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor Biochem J 367 Pt 3 2002 907 911
94. L. Davies, N. Karthikeyan, J.T. Lynch, E.A. Sial, A. Gkourtsa, and C. Demonacos Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function Mol Endocrinol 22 6 2008 1331 1344
95. S. Rogers, R. Wells, and M. Rechsteiner Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis Science 234 4774 1986 364 368
96. J.C. Webster, C.M. Jewell, J.E. Bodwell, A. Munck, M. Sar, and J.A. Cidlowski Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein J Biol Chem 272 14 1997 9287 9293
97. H. Garside, C. Waters, A. Berry, L. Rice, H.C. Ardley, and A. White UbcH7 interacts with the glucocorticoid receptor and mediates receptor autoregulation J Endocrinol 190 3 2006 621 629
98. D.Y. Leung, R.J. Martin, S.J. Szefler, E.R. Sher, S. Ying, and A.B. Kay Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma J Exp Med 181 1 1995 33 40
99. E. Irusen, J.G. Matthews, A. Takahashi, P.J. Barnes, K.F. Chung, and I.M. Adcock P38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma J Allergy Clin Immunol 109 4 2002 649 657
100. J.G. Matthews, K. Ito, P.J. Barnes, and I.M. Adcock Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients J Allergy Clin Immunol 113 6 2004 1100 1108
101. E.R. Sher, D.Y. Leung, W. Surs, J.C. Kam, G. Zieg, and A.K. Kamada Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy J Clin Invest 93 1 1994 33 39
102. P. Bhavsar, M. Hew, N. Khorasani, A. Torrego, P.J. Barnes, and I. Adcock Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma Thorax 63 9 2008 784 790
103. Y. Ishiguro Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis J Gastroenterol 34 1 1999 66 74
104. H. Flaster, J. Bernhagen, T. Calandra, and R. Bucala The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity Mol Endocrinol 21 6 2007 1267 1280
105. T. Roger, A.L. Chanson, M. Knaup-Reymond, and T. Calandra Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1 Eur J Immunol 35 12 2005 3405 3413
106. A. Kudrin, M. Scott, S. Martin, C.W. Chung, R. Donn, and A. McMaster Human macrophage migration inhibitory factor: a proven immunomodulatory cytokine? J Biol Chem 281 40 2006 29641 29651
107. P.J. Barnes, K. Ito, and I.M. Adcock Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase Lancet 363 9410 2004 731 733
108. M. Hew, P. Bhavsar, A. Torrego, S. Meah, N. Khorasani, and P.J. Barnes Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma Am J Respir Crit Care Med 174 2 2006 134 141
109. I.M. Adcock, K. Ito, and P.J. Barnes Histone deacetylation: an important mechanism in inflammatory lung diseases COPD 2 4 2005 445 455
110. K. Ito, M. Ito, W.M. Elliott, B. Cosio, G. Caramori, and O.M. Kon Decreased histone deacetylase activity in chronic obstructive pulmonary disease N Engl J Med 352 19 2005 1967 1976
111. K. Ito, T. Hanazawa, K. Tomita, P.J. Barnes, and I.M. Adcock Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration Biochem Biophys Res Commun 315 1 2004 240 245
112. Y. To, K. Ito, Y. Kizawa, M. Failla, M. Ito, and T. Kusama Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease Am J Respir Crit Care Med 182 7 2010 897 904
113. T. Bodamyali, C.R. Stevens, M.E. Billingham, S. Ohta, and D.R. Blake Influence of hypoxia in inflammatory synovitis Ann Rheum Dis 57 12 1998 703 710
114. J. Karhausen, V.H. Haase, and S.P. Colgan Inflammatory hypoxia: role of hypoxia-inducible factor Cell Cycle 4 2 2005 256 258
115. T. Murata, M. Hori, K. Sakamoto, H. Karaki, and H. Ozaki Dexamethasone blocks hypoxia-induced endothelial dysfunction in organ-cultured pulmonary arteries Am J Respir Crit Care Med 170 6 2004 647 655
116. T. Kodama, N. Shimizu, N. Yoshikawa, Y. Makino, R. Ouchida, and K. Okamoto Role of the glucocorticoid receptor for regulation of hypoxia-dependent gene expression J Biol Chem 278 35 2003 33384 33391
117. A.E. Wagner, G. Huck, D.P. Stiehl, W. Jelkmann, and T. Hellwig-Burgel Dexamethasone impairs hypoxia-inducible factor-1 function Biochem Biophys Res Commun 372 2 2008 336 340
118. H. Kitagawa, I. Yamaoka, C. Akimoto, I. Kase, Y. Mezaki, and T. Shimizu A reduction state potentiates the glucocorticoid response through receptor protein stabilization Genes Cells 12 11 2007 1281 1287
119. M.O. Leonard, C. Godson, H.R. Brady, and C.T. Taylor Potentiation of glucocorticoid activity in hypoxia through induction of the glucocorticoid receptor J Immunol 174 4 2005 2250 2257
120. T.D. Halazonetis, K. Georgopoulos, M.E. Greenberg, and P. Leder C-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities Cell 55 5 1988 917 924
121. C.Y. Wang, A.G. Bassuk, L.H. Boise, C.B. Thompson, R. Bravo, and J.M. Leiden Activation of the granulocyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors Mol Cell Biol 14 2 1994 Feb 1153 1159
122. R.P. de Groot, T.B. van Dijk, E. Caldenhoven, P.J. Coffer, J.A. Raaijmakers, and J.W. Lammers Activation of 12-O-tetradecanoylphorbol-13-acetate response element- and dyad symmetry element-dependent transcription by interleukin-5 is mediated by Jun N-terminal kinase/stress-activated protein kinase kinases J Biol Chem 272 4 1997 2319 2325
123. S.J. Lane, I.M. Adcock, D. Richards, C. Hawrylowicz, P.J. Barnes, and T.H. Lee Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes J Clin Invest 102 12 1998 2156 2164
124. I.M. Adcock, S.J. Lane, C.R. Brown, T.H. Lee, and P.J. Barnes Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma J Exp Med 182 6 1995 1951 1958
125. T.K. Loke, K.H. Mallett, J. Ratoff, B.J. O'Connor, S. Ying, and Q. Meng Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid- resistant asthmatic patients J Allergy Clin Immunol 118 2 2006 368 375
126. M.I. Diamond, J.N. Miner, S.K. Yoshinaga, and K.R. Yamamoto Transcription factor interactions: selectors of positive or negative regulation from a single DNA element Science 249 4974 1990 1266 1272
127. H.F. Yang-Yen, J.C. Chambard, Y.L. Sun, T. Smeal, T.J. Schmidt, and J. Drouin Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction Cell 62 6 1990 1205 1215
128. M. Yamauchi, Y. Ogata, R.H. Kim, J.J. Li, L.P. Freedman, and J. Sodek AP-1 regulation of the rat bone sialoprotein gene transcription is mediated through a TPA response element within a glucocorticoid response unit in the gene promoter Matrix Biol 15 2 1996 119 130
129. S.C. Biddie, B.L. Conway-Campbell, and S.L. Lightman Dynamic regulation of glucocorticoid signalling in health and disease Rheumatology (Oxford) 5 2011
130. N. Vasavda, T. Eichholtz, A. Takahashi, K. Affleck, J.G. Matthews, and P.J. Barnes Expression of nonmuscle cofilin-1 and steroid responsiveness in severe asthma J Allergy Clin Immunol 118 5 2006 1090 1096
131. G. Schlossmacher, A. Stevens, and A. White Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells J Endocrinol 211 1 2011 17 25
132. P. Sommer, P. Le Rouzic, H. Gillingham, A. Berry, M. Kayahara, and T. Huynh Glucocorticoid receptor overexpression exerts an antisurvival effect on human small cell lung cancer cells Oncogene 2007
133. P. Sommer, R.L. Cowen, A. Berry, A. Cookson, B.A. Telfer, and K.J. Williams Glucocorticoid receptor over-expression promotes human small cell lung cancer apoptosis in vivo and thereby slows tumor growth Endocr Relat Cancer 17 1 2010 203 213
134. B.G. Cosio, L. Tsaprouni, K. Ito, E. Jazrawi, I.M. Adcock, and P.J. Barnes Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages J Exp Med 200 5 2004 689 695
135. J.A. Marwick, G. Caramori, C.S. Stevenson, P. Casolari, E. Jazrawi, and P.J. Barnes Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice Am J Respir Crit Care Med 179 7 2009 542 548
136. S. Nobili, I. Landini, B. Giglioni, and E. Mini Pharmacological strategies for overcoming multidrug resistance Curr Drug Targets 7 7 2006 861 879
137. A.Y. Hoi, M.N. Iskander, and E.F. Morand Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseases Inflamm Allergy Drug Targets 6 3 2007 183 190
138. A. McMaster, and D.W. Ray Drug insight: selective agonists and antagonists of the glucocorticoid receptor Nat Clin Pract Endocrinol Metab 4 2 2008 91 101